Canada myocardial infarction market is estimated to grow modestly at a CAGR of around 8.3% during the forecast period. Canada has a considerable market of myocardial infarction treatment due to the presence of a huge patient pool suffering from persisting heart diseases such as CVD, CHD, stroke, hypertension, and other heart diseases. Canada contributes significantly to the MI treatment market due to the huge investment of government in healthcare facilities, R&D, and the adoption of innovative technologies in the healthcare domain. According to the Canadian Institute of Health Research, more than 1.6 million Canadians are suffering from heart disease. It is the second-leading cause of mortality in Canada after cancer. Nine in 10 Canadians over the age of 20 have at least one risk factor involving heart disease. Many health charities invest millions of dollars in research, health promotion, and community programs in Canada. For instance, the Heart and Stroke foundation invested more than $91 million in R&D of heart diseases and surgeries.
Please read the originial post here: https://www.omrglobal.com/industry-reports/canada-myocardial-infarction-market